T40.992D Poisoning by other psychodysleptics [hallucinogens], intentional self-harm, subsequent encounter

Name of the Condition

• Poisoning by other psychodysleptics [hallucinogens], intentional self-harm, subsequent encounter

Summary

This ICD code describes poisoning resulting from the intentional self-harm use of other psychodysleptics (hallucinogens) during a subsequent encounter. It applies to cases where a patient intentionally exposes themselves to these substances, leading to toxic effects, and is receiving ongoing care following an initial encounter. Psychodysleptics alter perception, mood, or consciousness, and their intentional self-harm can result in acute physiological or psychological symptoms requiring continued medical attention.

Causes

Intentional self-harm poisoning may occur from deliberate ingestion or exposure to hallucinogens, such as mescaline, DMT, or other substances not classified elsewhere. It can result from attempts at self-harm, substance misuse, or experimentation with high doses. Interactions with other substances may exacerbate toxicity, and underlying mental health conditions may contribute to the behavior.

Risk Factors

• History of intentional self-harm or suicidal ideation.
• Concurrent use of multiple psychoactive substances.
• Underlying mental health disorders (e.g., depression, anxiety).
• Access to hallucinogens.
• Lack of social support or supervision.

Symptoms

• Altered perception, including visual or auditory hallucinations.
• Anxiety, paranoia, or panic.
• Disorientation or confusion.
• Increased heart rate or blood pressure.
• Nausea, vomiting, or dizziness.
• Potential for severe psychological distress or agitation.

Diagnosis

Diagnosis involves clinical evaluation of symptoms, patient history (including intentional self-harm), and toxicology screening to identify the specific hallucinogen involved. Physical examination may reveal signs of toxicity, and mental health assessment is critical to address underlying conditions. Documentation of the intentional self-harm and subsequent encounter context is essential for accurate coding.

Treatment Options

Treatment focuses on stabilizing the patient, managing acute symptoms (e.g., agitation, cardiovascular effects), and providing psychological support. Interventions may include monitoring, supportive care, and addressing any co-occurring substance use or mental health issues. Referral to mental health services is often necessary for ongoing care.

Prognosis and Follow-Up

Prognosis depends on the severity of poisoning, timely intervention, and underlying mental health status. Subsequent encounters require ongoing monitoring to prevent recurrence and address psychological needs. Follow-up care may involve therapy, medication management, and support systems to reduce future risk.

Complications

• Severe psychological distress or psychosis.
• Cardiovascular instability (e.g., hypertension, tachycardia).
• Respiratory depression (in rare cases).
• Long-term mental health effects, such as persistent hallucinations or anxiety.
• Risk of repeated intentional self-harm.

Lifestyle & Prevention

• Secure storage of hallucinogens to prevent access.
• Mental health support and therapy to address underlying issues.
• Education on the risks of intentional self-harm and substance misuse.
• Building strong support networks (family, friends, professionals).

When to Seek Professional Help

Seek immediate medical attention if symptoms of poisoning occur, especially after intentional self-harm. Ongoing care is critical for subsequent encounters to manage physical and psychological effects and prevent recurrence.

Tips for Medical Coders

Document the intentional self-harm context and subsequent encounter clearly. Ensure the hallucinogen type is specified if known, and note any related mental health conditions. Verify that the encounter is classified as "subsequent" (not initial or acute) to align with the code’s requirements.